Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Critical Reviews in Oncology/Hematology
|
May 14, 2011
Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study
Gilles Freyer, Mario Campone, Julien Peron, et al.
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Exploring Determinants of Compassionate Cancer Care in Older Adults Using Fuzzy Cognitive Mapping
Dominique Tremblay, Chiara Russo, Catherine Terret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors
Jeany M Rademaker-Lakhai, Catherine Terret, Stephen B Howell, et al.
The Lancet. Oncology
|
April 4, 2012
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Laura Biganzoli, Hans Wildiers, Catherine Oakman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 28, 2017
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study
Eric Angevin, Philippe A Cassier, Antoine Italiano, et al.
The Oncologist
|
June 16, 2020
Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic Findings
Mansoor Saleh, Philippe A Cassier, Lauriane Eberst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2024
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial
Allison Voisin, Catherine Terret, Camille Schiffler, et al.
Journal of Geriatric Oncology
|
February 13, 2026
Individualized physical activity program for older adults undergoing chemotherapy for hematologic malignancies
Baptiste Fournier, Chiara Russo, Aurélia Maire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2021
A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, with or without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer
Komal Jhaveri, Dejan Juric, Yoon-Sim Yap, et al.
Breast (Edinburgh, Scotland)
|
May 26, 2026
Characteristics, treatment and survival of older patients with metastatic triple negative breast cancer from the ESME mBC real-world national cohort: a comparison with younger women
Mathilde Mairé, Fanny Bouteiller, Camille Chakiba, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Critical Reviews in Oncology/Hematology
|
May 14, 2011
Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study
Gilles Freyer, Mario Campone, Julien Peron, et al.
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Exploring Determinants of Compassionate Cancer Care in Older Adults Using Fuzzy Cognitive Mapping
Dominique Tremblay, Chiara Russo, Catherine Terret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors
Jeany M Rademaker-Lakhai, Catherine Terret, Stephen B Howell, et al.
The Lancet. Oncology
|
April 4, 2012
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Laura Biganzoli, Hans Wildiers, Catherine Oakman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 28, 2017
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study
Eric Angevin, Philippe A Cassier, Antoine Italiano, et al.
The Oncologist
|
June 16, 2020
Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic Findings
Mansoor Saleh, Philippe A Cassier, Lauriane Eberst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2024
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial
Allison Voisin, Catherine Terret, Camille Schiffler, et al.
Journal of Geriatric Oncology
|
February 13, 2026
Individualized physical activity program for older adults undergoing chemotherapy for hematologic malignancies
Baptiste Fournier, Chiara Russo, Aurélia Maire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2021
A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, with or without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer
Komal Jhaveri, Dejan Juric, Yoon-Sim Yap, et al.
Breast (Edinburgh, Scotland)
|
May 26, 2026
Characteristics, treatment and survival of older patients with metastatic triple negative breast cancer from the ESME mBC real-world national cohort: a comparison with younger women
Mathilde Mairé, Fanny Bouteiller, Camille Chakiba, et al.
Page
of 5